David Feltl

Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study

J.F.R. Robertson, Antonio Llombart‐Cussac, Janusz Rolski et al. · Journal of Clinical Oncology · 2009 · 311 citations

Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

Matthew J. Ellis, Antonio Llombart‐Cussac, David Feltl et al. · Journal of Clinical Oncology · 2015 · 233 citations · Full text

Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study

J.F.R. Robertson, Justin P.O. Lindemann, Antonio Llombart‐Cussac et al. · Breast Cancer Research and Treatment · 2012 · 171 citations

Advanced Breast Cancer, Breast Oncology, Medicine +8

Stereotactic radiosurgery for ablation of ventricular tachycardia

Radek Neuwirth, Jakub Cvek, Lukáš Knybel et al. · EP Europace · 2019 · 170 citations · Full text

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

Michaël Baumann, Thomas Herrmann, R. Koch et al. · Radiotherapy and Oncology · 2011 · 152 citations

Adaptive Radiotherapy, Final Results, Radiation Medicine +9